Обструкция мочеточника при раке поджелудочной железы

Обструкция мочеточника при раке поджелудочной железы

Автор: Перепечин Д.В., Качмазов А.А., Кононенко И.Б., Адамова Я.Г., Снеговой А.В., Векильян М.А., Аполихин О.И., Каприн А.Д.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Онкоурология

Статья в выпуске: 4 т.16, 2023 года.

Бесплатный доступ

Введение. Лечение больных с аденокарциномой поджелудочной железы, у которых появились метастазы в мочеточник с последующим гидро-уретеронефрозом, является крайне редким явлением в клинической практике. Зафиксировано только восемь подобных случаев. Свежих обзоров по этой теме не существует. Это побудило нас подготовить обзор о случаях аденокарциномы поджелудочной железы с метастазами в мочеточник.

Мочеточник, метастазы, метастаз в мочеточник, рак поджелудочной железы, гидронефроз

Короткий адрес: https://sciup.org/142240799

IDR: 142240799   |   DOI: 10.29188/2222-8543-2023-16-4-120-129

Список литературы Обструкция мочеточника при раке поджелудочной железы

  • Katsuno G, Kagawa S, Kokudo Y, Muraoka A, Tatemoto A, Sone Y, et al. Ureteral metastasis from appendiceal cancer: report of a case. Surg Today 2005;35(2):168–71. https://doi.org/10.1007/s00595-004-2876-4.
  • Roy S, Baijal SS. Pancreatic adenocarcinoma presenting with ureteric metastases. Case report and review of literature. Clin Imaging 1993;17(2):99-103. https://doi.org/10.1016/0899-7071(93)90045-o.
  • IX. Stow B. Fibrolymphosarcomata of both ureters metastatic to a primary lymphosarcomata of the anterior mediastinum of thymus origin. Ann Surg 1909;50(5):901-6. https://doi.org/10.1097/00000658-190911000-00009.
  • Talreja D, Opfell RW. Ureteral metastasis in carcinoma of the breast. West J Med 1980;133(3):252-4.
  • Haddad FS. Metastases to the ureter. Review of the world literature, and three new case reports. J Med Liban 1999;47(4):265-71.
  • Maclean JT, Fowler VB. Pathology of tumors of the renal pelvis and ureter. J Urol 1956;75(3):384-415. https://doi.org/10.1016/S0022-5347(17)66826.
  • Cohen WM, Freed SZ, Hasson J. Metastatic cancer to the ureter: a review of the literature and case presentations. J Urol 1974;112(2):188-9. https://doi.org/10.1016/s0022-5347(17)59679-2.
  • Geller SA, Lin C. Ureteral obstruction from metastatic breast carcinoma. Arch Pathol 1975;99(9):476-8.
  • Winalski CS, Lipman JC, Tumeh SS. Ureteral neoplasms. Radiographics 1990;10(2):271-83. https://doi.org/10.1148/radiographics.10.2.2183298.
  • Thorup B, Fabrin K, Lund L. Implantation metastasis in ureter from a colonic adenocarcinoma. Scand J Urol Nephrol 2001;35(5):420-1. https://doi.org/10.1080/003655901753224512.
  • Schwarz A. Pathology of the ureter. In Bergman H. editor. The Ureter. 2-nd ed. New York: Springer-Heidelberg 1981. P. 105-136.
  • Marincek B, Scheidegger JR, Studer UE, Kraft R. Metastatic disease of the ureter: patterns of tumoral spread and radiologic findings. Abdom Imaging 1993;18(1):88-94. https://doi.org/10.1007/BF00201710.
  • Fitch WP, Robinson JR, Radwin HW. Metastatic carcinoma of the ureter. Arch Surg 1976;111(8):874-6. https://doi.org/10.1001/archsurg.1976.01360260042010.
  • Richie JP, Withers G, Ehrlich RM. Ureteral obstruction secondary to metastatic tumors. Surg Gynecol Obstet 1979;148(3):355-7.
  • Witten D, Myers GH Jr, Utz DC, editors. Emmett’s Clinical Urography: An Atlas and Textbook of Roentgenologic Diagnosis. 4th ed. Philadelphia: WB Saunders; 1977.
  • Stearns DB, Gordon SK. Ureteral metastasis secondary to carcinoma of the large bowel. Am J Surg 1960;99:244-6. https://doi.org/10.1016/0002-9610(60)90121-5.
  • Alexander S, Kim K, Pinck BD, Brendler H. Metastatic ureteral tumors. J Urol 1973;110(3):288-90. https://doi.org/10.1016/s0022-5347(17)60189-7.
  • Presman D, Ehrlich L. Metastatic tumors of the ureter. J Urol 1948;59(3):312-25. https://doi.org/10.1016/S0022-5347(17)69379-0.
  • Mackenzie DW, Ratner M. Metastatic growths in the ureter: a report of three cases and a brief review of the literature. Can Med Assoc J 1931;25(3):265-70.
  • Bechtold RB, Chen MY, Dyer RB, Zagoria RJ. CT of the ureteral wall. AJR Am J Roentgenol 1998;170(5):1283-9. https://doi.org/10.2214/ajr.170.5.9574602.
  • Grabstald H, Kaufman R. Hydronephrosis secondary to ureteral obstruction by metastatic breast cancer. J Urol 1969;102(5):569-76. https://doi.org/10.1016/s0022-5347(17)62202-x.
  • Babaian RJ, Johnson DE, Ayala AG, Sie ET. Secondary tumors of ureter. Urology 1979;14(4):341-3. https://doi.org/10.1016/0090-4295(79)90075-x.
  • Goel AK, Rao MS, Mathur RP, Vaidyanathan S, Sen TK, Suryaprakash B, Malik AK. Bilateral ureteric and renal pelvic invasion by metastatic oesophageal carcinoma (a case report). J Postgrad Med 1985;31(4):212-4.
  • Shimoyama Y, Ohashi M, Hashiguchi N, Ishihara M, Sakata M, Tamura A, et al. Gastric cancer recognized by metastasis to the ureter. Gastric Cancer 2000;3(2):102-5. https://doi.org/10.1007/pl00011693.
  • Benejam R, Carroll TJ, Loening S. Prostate carcinoma metastatic to ureter. Urology 1987;29(3):325-7. https://doi.org/10.1016/0090-4295(87)90084-7.
  • Wanuck S, Schwimmer R, Orkin L. Carcinoma of the pancreas causing ureteral obstruction. J Urol 1973;110(4):395-6. https://doi.org/10.1016/s0022-5347(17)60230-1.
  • Puech JL, Song MY, Joffre F, Rousseau H, Trocard J, Plante P. Ureteral metastases-computed tomographic findings. Eur J Radiol 1987;7(2):103-6.
  • Ambos MA, Bosniak MA, Megibow AJ, Raghavendra B. Ureteral involvement by metastatic disease. Urol Radiol 1979;1(2):105-12. https://doi.org/10.1007/BF02926610.
  • Giuliano AE, Sparks FC, Morton DL. Breast cancer presenting as renal colic. Am J Surg 1978;135(6):842-5. https://doi.org/10.1016/0002-9610(78)
  • Schmidt JD. Bilateral ureteral obstruction due to cancer of the pancreas. J Urol 1971;106(5):652-4. https://doi.org/10.1016/s0022-5347(17)61366-1.
  • Vandendris M. Complete bilateral ureteral obstruction secondary to pancreatic carcinoma. Eur Urol 1976;2(1):43-4. https://doi.org/10.1159/000471957.
  • Eisenkraft S, Jonas P, Mani M. Left nephroureteric obstruction due to carcinoma of the pancreatic tail. Br J Urol 1986;58:97–98.
  • Stenner J, Arista-Nasr J, Leñero-Llaca E, Keirns C, Gabilondo-Navarro F. Adenocarcinoma of the ampulla of Vater and head of the pancreas metastatic to the ureter: report of 2 cases. J Urol 1996;156(5):1765.
  • Arvind NK, Singh O, Gupta S, Ali Q. Ureteral metastasis as the presenting manifestation of pancreatic carcinoma. Rev Urol 2013;15(3):124-30.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
  • Кубышкин В.А., Вишневский В.А. Рак поджелудочной железы. М: Медпрактика-М. 2003;375 с. [Kubyshkin V.A., Vishnevsky V.A. Pancreas cancer. M: Medpraktika-M. 2003; Medpraktika-M. 2003; 375 p. (In Russian)].
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
  • Hidalgo M, Cascinu S, Kleeff J, Labianca R, Löhr JM, Neoptolemos J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology 2015;15(1):8-18. https://doi.org/10.1016/j.pan.2014.10.001.
  • De La Cruz MS, Young AP, Ruffin MT. Diagnosis and management of pancreatic cancer. Am Fam Physician 2014;89(8):626-32.
  • Ветшева Н.Н., Кармазановский Г.Г., Степанова Ю.А. Инструментальные методы диагностики в оценке сосудистой инвазии при опухолях поджелудочной железы. Медицинская визуализация 2013;(4):136-9. [Vetsheva N.N., Karmazanovsky G.G., Stepanova Yu.A. Instrumental methods of diagnosis in the assessment of vascular invasion by tumors of the pancreas. Meditsinskaya vizualizatsiya = Medical Visualization 2013;(4):136-9. (In Russian)].
  • Кубышкин В.А. Периампулярные опухоли. Тихоокеанский медицинский журнал 2009;(2):53-6. [Kubyishkin V.A. Periampullary tumors. Tihookeanskij medicinskij žurnal = Pacific Medical Journal 2009;(2):53-6. (In Russian)].
  • Zakaria A, Al-Share B, Klapman JB, Dam A. The role of endoscopic ultrasonography in the diagnosis and staging of pancreatic cancer. Cancers (Basel) 2022;14(6):1373. https://doi.org/10.3390/cancers14061373.
  • Rocha Lima CM, Green MR, Rotche R, Miller WH Jr, Jeffrey GM, Cisar LA, et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. J Clin Oncol 2004;22(18):3776–83. https://doi.org/10.1200/JCO.2004.12.082.
  • Wang L, Xiong L, Wu Z, Miao X, Liu Z, Li D, et al. Expression of Ugp2 and Cfl1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance. World J Surg Oncol 2018;16(1):11. https://doi.org/10.1186/s12957-018-1316-7.
  • Strobel O, Neoptolemos J, Jager D, Buchler MW. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol 2019;16(1):11–26. https://doi.org/10.1038/s41571-018-0112-1
  • Antoniou E, Margonis GA, Sasaki K, Andreatos N, Polychronidis G, Pawlik TM, et al. Is resection of pancreatic adenocarcinoma with synchronous hepatic metastasis justified? A review of current literature. ANZ J Surg (2016) 86(12):973–7. https://doi.org/10.1111/ans.13738.
  • Embuscado EE, Laheru D, Ricci F, Yun KJ, de Boom Witzel S, Seigel A, et al. Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther 2005;4(5):548–54. https://doi.org/10.4161/cbt.4.5.1663.
  • Giovannetti E, van der Borden CL, Frampton AE, Ali A, Firuzi O, Peters GJ. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Semin Cancer Biol 2017;44:43-59. https://doi.org/10.1016/j.semcancer.2017.04.006.
  • Патютко Ю.И., Котельников А.Г. Хирургия рака органов билиопанкреатической зоны. М: Медицина 2007. 448 c. [Patyutko Yu.I., Kotelnikov A.G. Surgery for cancer of the organs of the biliopancreatic zone. M: Medicine 2007.448 p. (In Russian)].
  • Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers 2016; 21:16022. https://doi.org/10.1038/nrdp.2016.22.
  • Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg 2018;267(5):936-45. https://doi.org/10.1097/SLA.0000000000002234.
  • Кригер А.Г. Кармазановский Г.Г., Горин Д.С., Кочатков А.В., Ветшева Н.Н., Берелавичус С.В. Диагностика и хирургическое лечение кистозных опухолей поджелудочной железы. Вестник экспериментальной и клинической хирургии 2012;5(1):26-32. [Kriger A.G., Karmazanovsky G.G., Gorin D.S., Kochatkov A.V., Vetsheva N.N., Berelavichus S.V. Diagnosis and surgical treatment of cystic pancreatic tumors. Vestnik Eksperimental'noy i Klinicheskoy Khirurgii = Bulletin of Experimental and Clinical Surgery 2012;5(1):26-32. (In Russian)].
  • Jemal A, Siegel R, Xu J, Ward E. Cancer statistic, 2010. CA Cancer Clin J 2010;60(5):277-300. https://doi.org/10.3322/caac.20073
  • Mavros MN, Moris D, Karanicolas PJ, Katz MHG, O'Reilly EM, Pawlik TM. Clinical trials of systemic chemotherapy for resectable pancreatic cancer: a review. JAMA Surg 2021;156(7):663-72. https://doi.org/10.1001/jamasurg.2021.0149
  • Захарова О.П., Кубышкин В.А., Кармазановский Г.Г. Протокол КТ-исследования при оценке резектабельности рака поджелудочной железы. Хирургия. Журнал им. Н.И. Пирогова 2012;(8):44-50. [Zakharova OP, Kubyshkin VA, Karmazanovskiĭ GG. The requirement for the CT-scan protocol for the proper assessment of pancreatic tumors resectability. Khirurgiya. zhurnal imeni N.I. Pirogova = Pirogov Russian Journal of Surgery 2012;(8):44-50. (In Russian)].
  • Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, et al. Association of clinical factors with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma. JAMA Surg 2017;152(11):1048–56. https://doi.org/10.1001/jamasurg.2017.2227
  • Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364(19):1817–25. https://doi.org/10.1056/NEJMoa1011923.
  • Каприн Д.А. Внутриартериальная регионарная химиотерапия рака поджелудочной железы (обзор литературы). Трансляционная медицина 2022;9(6):16-25. https://doi.org/10.18705/2311-44952022-9-6-16-25 [Kaprin D.A. Intra-arterial regional chemotherapy for pancreatic cancer (review). Translyatsionnaya Meditsina = Translational Medicine. 2022;9(6):16-25. (In Russian)]. https://doi.org/10.18705/2311-44952022-9-6-16-25.
  • Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, et al. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 2016;387(10018):545-57. https://doi.org/10.1016/S0140-6736(15)00986-1.
  • Goldman SM, Gatewood OMB. Neoplasms of the renal collecting system, pelvis, and ureter. In: Pollack HM, editor. Clinical Urography. An Atlas and Textbook of Urologic Imaging. Philadelphia: W.B. Saunders; 1999. P. 1339–49.
  • Luciani L, Scappini P, Pusiol T, Piscioli F. The role of aspiration cytology in the management of ureteral obstruction in patients with known cancer. Cancer 1987;59(11):1936-46. https://doi.org/10.1002/1097-0142(19870601)59:11<1936:: aid-cncr2820591117-3.0.co;2-q.
  • WHO Classification of Tumors online. Digestive system tumours (5th ed.). Tumors of pancreas. P. 12.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp